PBYI
Puma Biotechnology, Inc.
9.50$
+1.4%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +806.1% | +8.5% | -17.3% | +12.5% | -9.9% | +3.3% | -2.2% | -0.9% | |
| – | – | +48.1% | +387.4% | +517.9% | +6.4% | +7.0% | +61.8% | -13.5% | +13.8% | +2.7% | -9.7% | |
| – | – | – | – | +879.2% | +8.8% | -21.1% | +2.0% | -8.7% | +0.0% | -4.0% | +2.5% | |
| – | +69.7% | +6.9% | -6.7% | -20.6% | -19.4% | -26.5% | -26.4% | -27.3% | -3.6% | +9.0% | +13.0% | |
| – | +63.9% | +69.2% | +98.3% | +37.0% | -3.9% | -15.7% | -1.9% | -22.6% | -1.7% | -8.8% | -11.7% | |
| – | +68.9% | +15.1% | +13.7% | -1.1% | 0.0% | -30.5% | -12.9% | -20.7% | -6.0% | -3.7% | -1.6% | |
| – | – | – | – | – | – | – | – | +1,738.8% | +37.6% | -5.1% | +20.5% | |
| – | +199.7% | -1.3% | -24.8% | +1,427.8% | +36.4% | -6.4% | -8.8% | -9.5% | +15.0% | -6.6% | -46.8% | |
| – | – | – | – | – | – | – | – | – | +4,861.5% | +6.3% | +48.5% | |
| – | – | – | – | – | – | +290.6% | +56.5% | +40.4% | +138.0% | -670.5% | – | |
| – | – | – | – | – | – | – | – | – | +1,079,450.0% | +40.2% | +2.8% | |
| – | – | – | – | – | – | – | – | – | +117.1% | +1.2% | +11.0% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.